Abselion
Series ACambridge, UKDec 2024
Abselion raised €8.0M in a Series A round in Dec 2024. The company is based in Cambridge, UK. Investors in the round: BGF, BioProcess 360 Partners, M Ventures and 2 others. Data as of Nov 2026.
Amount raised
€8.0M
€7,970,533
Native amount
6,600,000 GBP
Stage
Series A
series a
Investors
5
Provenance & confidence
High confidenceAmount
6,600,000 GBP
ECB-at-date → €8.0M · rate 0.82805 on 2024-12-09
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Dec 2024
Round type
series a
Amount (EUR)
€8.0M
Other rounds
same companyThis is the company's only recorded round.